GlassScriptPhysician profile
Robert D Henihan
NPI 1912950403
$7,321.68
in general payments reported to CMS, 2019-2025
41 companies · $468 in 2025
The $468 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $783 · 2020: $276 · 2021: $446 · 2022: $1,592 · 2023: $1,803 · 2024: $1,954 · 2025: $468.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,225.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,225.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,526.00 | 2019-2025 | |
| Janssen Biotech, INC. | $712.34 | 2019-2025 | Tremfya, Stelara, Remicade |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $603.34 | 2019-2024 | Xifaxan, Plenvu |
| Boston Scientific Corporation | $363.19 | 2020-2023 | Exalt Model D |
| Gilead Sciences, INC. | $296.85 | 2021-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $260.26 | 2019-2024 | Entyvio |
| Pfizer INC. | $233.60 | 2019-2023 | |
| Conmed Corporation | $202.83 | 2024 | Conmed Hemostasis, Conmed Biliary, Conmed Generators |
| Ferring Pharmaceuticals INC. | $185.08 | 2022-2023 | Rebyota |
| Medtronic, INC. | $154.35 | 2022 | |
| Genzyme Corporation | $131.28 | 2024 | |
| Lilly USA, LLC | $129.76 | 2024-2025 | Omvoh |
| E.R. Squibb & Sons, L.L.C. | $116.84 | 2023 | Zeposia |
| Ardelyx, INC. | $115.28 | 2022-2025 | Ibsrela |
| Intercept Pharmaceuticals, INC. | $112.79 | 2019-2025 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Henihan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.